Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 2/2020

05.06.2019 | Echocardiography

Long-term development of radiation exposure, fluoroscopy time and contrast media use in daily routine in cryoballoon ablations after implementation of intracardiac echocardiography and other radioprotective measures: experiences from a large single-centre cohort

verfasst von: Vanessa Rubesch-Kütemeyer, Thomas Fischbach, Denise Guckel, Britta Körber, Dieter Horstkotte, Klaus-Jürgen Gutleben, Georg Nölker

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The concern of higher radiation exposure during cryoballoon ablation (CBA) compared with radiofrequency ablation for atrial fibrillation (AF) was raised before. Previously, we compared CBA plus intracardiac echocardiography (ICE) to our former standard approach without ICE. A substantial reduction of radiation exposure without compromising safety or outcome was observed. We now investigate if at all and possibly to which amount radiation reduction can be achieved with growing experience.

Methods

We retrospectively analysed procedure time, dose area product (DAP), fluoroscopy time (FT) and contrast media (CM) use for all patients receiving CBA between 2013 and 2017 for AF.

Results

In 1131 procedures, procedure time decreased significantly between 2013 and 2017 (2013 111 ± 26 min, 2017 99 ± 25 min, p = 0.005). DAP halved between 2013 and 2014 without further significant decline (2013 1428 ± 1276 cGycm2, 2014 725 ± 551 cGycm2, p < 0.001). FT demonstrated a constant decrease from 2013 to 2017 (2013 11.7 ± 5.5 min, 2017 5.1 ± 3.5 min, p < 0.001). CM use did not show a significant reduction comparing 2013 to 2017 (2013 62 ± 19 ml, 2017 59 ± 18 ml, 2013/2017 p = 0.584).

Conclusion

Given the imminent negative effects of radiation, every effort should be undertaken for its reduction. Feasible protocols can be kept simple by technical changes as reducing frame rates and basic radiation reduction strategies such as collimation, but ICE might add additional benefit. With growing experience and awareness of radioprotection, DAP and FT as low as or lower than in radiofrequency ablations seem possible.
Literatur
1.
Zurück zum Zitat Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–78.CrossRef Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–78.CrossRef
2.
Zurück zum Zitat Buiatti A, von Olshausen G, Barthel P, Schneider S, Luik A, Kaess B, et al. Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated meta-analysis of randomized and observational studies. Europace. 2017;19:378–84.CrossRef Buiatti A, von Olshausen G, Barthel P, Schneider S, Luik A, Kaess B, et al. Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated meta-analysis of randomized and observational studies. Europace. 2017;19:378–84.CrossRef
3.
Zurück zum Zitat Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–45.CrossRef Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–45.CrossRef
4.
Zurück zum Zitat Omran H, Gutleben KJ, Molatta S, Fischbach T, Wellmann B, Horstkotte D, et al. Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis. Clin Res Cardiol. 2018;107:182–92.CrossRef Omran H, Gutleben KJ, Molatta S, Fischbach T, Wellmann B, Horstkotte D, et al. Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis. Clin Res Cardiol. 2018;107:182–92.CrossRef
5.
Zurück zum Zitat Straube F, Dorwarth UF, Ammar- Busch S, Peter T, Noelker G, Massa T, et al. First-line ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation. Europace. 2016;18:368–75.CrossRef Straube F, Dorwarth UF, Ammar- Busch S, Peter T, Noelker G, Massa T, et al. First-line ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation. Europace. 2016;18:368–75.CrossRef
6.
Zurück zum Zitat Kuck K, Fürnkranz A, Chun JKR, Metzner A, Ouyang F, Schlüter M, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37:2858–65.CrossRef Kuck K, Fürnkranz A, Chun JKR, Metzner A, Ouyang F, Schlüter M, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37:2858–65.CrossRef
7.
Zurück zum Zitat Heidbuchel H, Wittkampf FHM, Vano E, Ernst S, Schilling R, Picano E, et al. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedure. Europace. 2014;16:946–64.CrossRef Heidbuchel H, Wittkampf FHM, Vano E, Ernst S, Schilling R, Picano E, et al. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedure. Europace. 2014;16:946–64.CrossRef
8.
Zurück zum Zitat Nölker G, Heintze J, Gutleben KJ, Muntean B, Pütz V, Yalda A, et al. Cryoballoon pulmonary vein isolation supported by intracardiac echocardiography: integration of a nonfluoroscopic imaging technique in atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2010;21:1325–30.CrossRef Nölker G, Heintze J, Gutleben KJ, Muntean B, Pütz V, Yalda A, et al. Cryoballoon pulmonary vein isolation supported by intracardiac echocardiography: integration of a nonfluoroscopic imaging technique in atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2010;21:1325–30.CrossRef
9.
Zurück zum Zitat Schmidt M, Daccarett M, Marschang H, Ritscher G, Turschner O, Brachmann J, et al. Intracardiac echocardiography improves procedural efficiency during cryoballoon ablation for atrial fibrillation: a pilot study. J Cardivasc Electrophysiol. 2010;21:1202–7.CrossRef Schmidt M, Daccarett M, Marschang H, Ritscher G, Turschner O, Brachmann J, et al. Intracardiac echocardiography improves procedural efficiency during cryoballoon ablation for atrial fibrillation: a pilot study. J Cardivasc Electrophysiol. 2010;21:1202–7.CrossRef
10.
Zurück zum Zitat Rubesch-Kütemeyer V, Molatta S, Vogt J, Gutleben KJ, Horstkotte D, Nölker G. Reduction of radiation exposure in cryoballoon ablation procedures: a single-centre study applying intracardiac echocardiography and other radioprotective measures. Europace. 2017;19:947–53.PubMed Rubesch-Kütemeyer V, Molatta S, Vogt J, Gutleben KJ, Horstkotte D, Nölker G. Reduction of radiation exposure in cryoballoon ablation procedures: a single-centre study applying intracardiac echocardiography and other radioprotective measures. Europace. 2017;19:947–53.PubMed
11.
Zurück zum Zitat Ector J, Dragusin O, Adriaenssens B, Huybrechts W, Willems R, Ector H, et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol. 2017;50:234–42.CrossRef Ector J, Dragusin O, Adriaenssens B, Huybrechts W, Willems R, Ector H, et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol. 2017;50:234–42.CrossRef
12.
Zurück zum Zitat Letsas KP, Siklódy CH, Korantzopoulos P, Weber R, Bürkle G, Mihas CC, et al. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol. 2013;164:94–8.CrossRef Letsas KP, Siklódy CH, Korantzopoulos P, Weber R, Bürkle G, Mihas CC, et al. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol. 2013;164:94–8.CrossRef
13.
Zurück zum Zitat Guhl EN, Siddoway D, Adelstein E, Voigt A, Saba S, Jain SK. Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:423–7.CrossRef Guhl EN, Siddoway D, Adelstein E, Voigt A, Saba S, Jain SK. Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:423–7.CrossRef
14.
Zurück zum Zitat Tscholl V, Lsharaf AK, Lin T, Bellmann B, Biewener S, Nagel P, et al. Two years outcome in patients with persistent atrial fibrillation after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Heart Rhythm. 2016;13:1817–22.CrossRef Tscholl V, Lsharaf AK, Lin T, Bellmann B, Biewener S, Nagel P, et al. Two years outcome in patients with persistent atrial fibrillation after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Heart Rhythm. 2016;13:1817–22.CrossRef
15.
Zurück zum Zitat Velagić V, de Asmundis C, Mugnai G, Hünük B, Hacioğlu E, Ströker E, et al. Learning curve using the second-generation cryoballoon ablation. J Cardiovasc Med. 2017;18:518–27.CrossRef Velagić V, de Asmundis C, Mugnai G, Hünük B, Hacioğlu E, Ströker E, et al. Learning curve using the second-generation cryoballoon ablation. J Cardiovasc Med. 2017;18:518–27.CrossRef
16.
Zurück zum Zitat Reissmann B, Maurer T, Wohlmuth P, Krüger M, Heeger C, Lemes C, et al. Significant reduction of radiation exposure in cryoballoon-based pulmonary vein isolation. Europace. 2018;20:608–13.CrossRef Reissmann B, Maurer T, Wohlmuth P, Krüger M, Heeger C, Lemes C, et al. Significant reduction of radiation exposure in cryoballoon-based pulmonary vein isolation. Europace. 2018;20:608–13.CrossRef
17.
Zurück zum Zitat Schmidt M, Dorwarth U, Andresen D, Brachmann J, Kuck KH, Kuniss M, et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol. 2014;25:1–7.CrossRef Schmidt M, Dorwarth U, Andresen D, Brachmann J, Kuck KH, Kuniss M, et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol. 2014;25:1–7.CrossRef
18.
Zurück zum Zitat Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nölker G. Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol. 2013;61:1707–12.CrossRef Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nölker G. Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol. 2013;61:1707–12.CrossRef
20.
Zurück zum Zitat Razminia M, Demo H, Arrieta-Garcia C, D’Silva OJ, Wang T, Kehoe RF. Nonfluoroscopic ablation of atrial fibrillation using cryoballoon. J Atr Fibrillation. 2014;7:1093.PubMedPubMedCentral Razminia M, Demo H, Arrieta-Garcia C, D’Silva OJ, Wang T, Kehoe RF. Nonfluoroscopic ablation of atrial fibrillation using cryoballoon. J Atr Fibrillation. 2014;7:1093.PubMedPubMedCentral
Metadaten
Titel
Long-term development of radiation exposure, fluoroscopy time and contrast media use in daily routine in cryoballoon ablations after implementation of intracardiac echocardiography and other radioprotective measures: experiences from a large single-centre cohort
verfasst von
Vanessa Rubesch-Kütemeyer
Thomas Fischbach
Denise Guckel
Britta Körber
Dieter Horstkotte
Klaus-Jürgen Gutleben
Georg Nölker
Publikationsdatum
05.06.2019
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2020
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-019-00564-5

Weitere Artikel der Ausgabe 2/2020

Journal of Interventional Cardiac Electrophysiology 2/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.